BRPI0418126A - método de diagnóstico sorológico e determinação de estatuto vacinal, compreendendo diferentes controles - Google Patents

método de diagnóstico sorológico e determinação de estatuto vacinal, compreendendo diferentes controles

Info

Publication number
BRPI0418126A
BRPI0418126A BRPI0418126-3A BRPI0418126A BRPI0418126A BR PI0418126 A BRPI0418126 A BR PI0418126A BR PI0418126 A BRPI0418126 A BR PI0418126A BR PI0418126 A BRPI0418126 A BR PI0418126A
Authority
BR
Brazil
Prior art keywords
vaccine
antigens
control
serological diagnosis
determination
Prior art date
Application number
BRPI0418126-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Claude Escorguel
Original Assignee
Inodiag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0315327A external-priority patent/FR2864624A1/fr
Priority claimed from FR0408600A external-priority patent/FR2874093B1/fr
Application filed by Inodiag filed Critical Inodiag
Publication of BRPI0418126A publication Critical patent/BRPI0418126A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Testing Of Engines (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
BRPI0418126-3A 2003-12-24 2004-12-23 método de diagnóstico sorológico e determinação de estatuto vacinal, compreendendo diferentes controles BRPI0418126A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0315327A FR2864624A1 (fr) 2003-12-24 2003-12-24 Methode de diagnostic serologique des maladies infectieuses par immunodetection d'antigene microbien comprenant le controle de reaction faussement positive ou negative
FR0408600A FR2874093B1 (fr) 2004-08-03 2004-08-03 Methode et trousse de determination du statut vaccinal de personnes
PCT/FR2004/003364 WO2005064340A2 (fr) 2003-12-24 2004-12-23 Methode de diagnostic serologique et determination de statut vaccinal comprenant differents controles

Publications (1)

Publication Number Publication Date
BRPI0418126A true BRPI0418126A (pt) 2007-04-10

Family

ID=34740714

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0418126-3A BRPI0418126A (pt) 2003-12-24 2004-12-23 método de diagnóstico sorológico e determinação de estatuto vacinal, compreendendo diferentes controles

Country Status (6)

Country Link
US (1) US20070160978A1 (de)
EP (1) EP1700128B1 (de)
AT (1) ATE439594T1 (de)
BR (1) BRPI0418126A (de)
DE (1) DE602004022588D1 (de)
WO (1) WO2005064340A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006027516B4 (de) * 2006-06-09 2021-10-07 Euroimmun Medizinische Labordiagnostika Ag Verfahren zur Optimierung der automatischen Fluoreszenzmustererkennung in der Immundiagnostik
WO2008065474A1 (en) * 2006-11-29 2008-06-05 Laboratorio Celsius S.A. Method for analyzing image data relating to agglutination assays
FR2918459B1 (fr) * 2007-07-04 2009-12-04 Inodiag Methode de diagnostic serologique multiplexe in vitro des infections a spirochetes
RU2472158C1 (ru) * 2011-11-30 2013-01-10 Федеральное государственное Бюджетное учреждение "Государственный научный центр дерматовенерологии и косметологии Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "ГНЦДК" Минздравсоцразвития России) Состав расширенной квалификационной панели контрольных материалов для осуществления внешнего и внутрилабораторного контроля качества серологической диагностики сифилитической инфекции
KR101341994B1 (ko) 2012-02-20 2013-12-16 대한민국 간접면역형광항체법에 의한 레지오넬라증 진단용 항원슬라이드의 제조방법 및 이를 이용한 마이크로 다가 항원슬라이드
CN102692502B (zh) * 2012-04-26 2015-02-04 北京北方生物技术研究所 一种快速检测甲型肝炎病毒IgM抗体的试剂盒及其制备方法
CN113567660A (zh) * 2021-07-22 2021-10-29 中南大学湘雅二医院 一种检测系统性红斑狼疮患者自身抗体的方法
CN120275649B (zh) * 2025-06-11 2025-08-26 上海交通大学医学院附属仁济医院 一种适用于制备检测抗核抗体荧光免疫层析试纸条的Hep-2细胞提取物制备工艺及试纸条的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD301364A7 (de) * 1990-04-19 1992-12-10 Berlin Buch Klinikum Verfahren zur Bestimmung von antinukleären Antikörpern
US5478753A (en) * 1993-06-29 1995-12-26 Pb Diagnostic Systems, Inc. Positive calibrator/control composition for an IgM serology assay and an IgM serology assay
DE19731465A1 (de) * 1997-07-22 1999-01-28 Boehringer Mannheim Gmbh Verwendung von Kontrollflächen zur Detektion von Störproben in einem Nachweisverfahren
ATE395598T1 (de) * 1998-04-14 2008-05-15 Otsuka Pharma Co Ltd Verfahren und vorrichtung zum nachweis von antikörpern
RU2213972C1 (ru) * 2002-09-19 2003-10-10 Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова РАМН Способ определения состояния гуморального иммунитета к условно-патогенным бактериям одновременным выявлением igg антител

Also Published As

Publication number Publication date
DE602004022588D1 (de) 2009-09-24
WO2005064340A2 (fr) 2005-07-14
EP1700128B1 (de) 2009-08-12
US20070160978A1 (en) 2007-07-12
EP1700128A2 (de) 2006-09-13
ATE439594T1 (de) 2009-08-15
WO2005064340A3 (fr) 2005-11-24

Similar Documents

Publication Publication Date Title
Bond et al. Evaluation of serological tests for SARS-CoV-2: implications for serology testing in a low-prevalence setting
HRP20220373T1 (hr) POSTUPAK I REAGENSI ZA DIJAGNOZU SARS-CoV-2
Howard et al. Basic methods in antibody production and characterization
Rowntree et al. Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody features
Hober et al. Systematic evaluation of SARS‐CoV‐2 antigens enables a highly specific and sensitive multiplex serological COVID‐19 assay
DE60141844D1 (de) Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen
BRPI0418126A (pt) método de diagnóstico sorológico e determinação de estatuto vacinal, compreendendo diferentes controles
Malik et al. Antibody techniques
Day Introduction to antigen and antibody assays
CN102965343A (zh) 分泌牛γ干扰素单克隆抗体的杂交瘤细胞株、其单克隆抗体及其应用
DE59209079D1 (de) Monoklonale Antikörper gegen humane Pankreas-Inselzellen
Brocchi et al. Development of two novel monoclonal antibody-based ELISAs for the detection of antibodies and the identification of swine isotypes against swine vesicular disease virus
Cerar et al. Humoral immune responses in patients with Lyme neuroborreliosis
Yin et al. Study on immunogenicity and antigenicity of a novel brucella multiepitope recombined protein
Kaida et al. Guillain–Barré syndrome with IgM antibody to the ganglioside GalNAc–GD1a
Smith et al. Local antibody production in experimental pyelonephritis: amount, avidity, and immunoglobulin class
DE3772242D1 (de) Reagenz fuer den nachweis von nicht-a-nicht-b-viraler hepatitis und verfahren zur diagnose von solcher hepatitis auf immunoenzymatischem wege.
Alberú et al. A non-allogeneic stimulus triggers the production of de novo HLA antibodies in healthy adults
Deshpande et al. Unveiling the quest: crafting an enzyme-linked immunosorbent assay (ELISA) technique to uncover COVID-19 antibodies
CA2589054A1 (en) Detection of a therapeutic antibody in an experimental animal
Hayashi et al. Elevated mycobacterium avium subsp. paratuberculosis (MAP) antibody titer in Japanese multiple sclerosis
WO2019194360A8 (ko) 개의 수혈 적합성 판별 방법, 및 이를 위한 키트, 단일클론항체 및 하이브리도마 세포주
KR20180020992A (ko) 피검 대상의 검출 방법 및 그것을 위한 면역 측정 기구 및 모노클로널 항체
Gürtürk et al. Detection of Campylobacter Antibodies in Sheep Sera by a Dot‐ELISA Using Acid Extracts from C. fetus ssp. fetus and C. jejuni Strains and Comparison with a Complement Fixation Test
JP2002306164A (ja) エボラウイルスを認識するモノクローナル抗体

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.